ASTRAZENECA Top Management

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>AP</div>
Evaluation of ASTRAZENECA PHARMA management performance can provide insight into the firm performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with ASTRAZENECA PHARMA future performance. Check out Trending Equities.
Symbol  ASTRAZEN
Name  ASTRAZENECA PHARMA INDIA
TypeStock
Country   India
Exchange  Bombay

Information on ASTRAZENECA PHARMA INDIA Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out.

BIDU   
Purchased over 90 shares of
a day ago
Traded for 123.3
HBI   
Purchased over 70 shares of
a day ago
Traded for 11.46
O   
Purchased few shares of
a day ago
Traded for 61.1
URI   
Purchased few shares of
a day ago
Traded for 147.91
SWKS   
Purchased few shares of
a day ago
Traded for 128.42

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

ASTRAZENECA PHARMA Management Team Effectiveness

ASTRAZENECA PHARMA has return on total asset (ROA) of 6.92 % which means that it generated profit of $6.92 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 19.88 %, meaning that it generated $19.88 on every $100 dollars invested by stockholders. ASTRAZENECA PHARMA management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.

ASTRAZENECA PHARMA Workforce Comparison

ASTRAZENECA PHARMA INDIA is number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers - Major industry is presently estimated at about 2,904. ASTRAZENECA PHARMA totals roughly 1,452 in number of employees claiming about 50% of equities under Drug Manufacturers - Major industry.

ASTRAZENECA PHARMA Profit Margins

The company has Profit Margin (PM) of 7.48 %, which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 7.77 % which suggests for every 100 dollars of sales it generated a net operating income of 0.08.
Check out Trending Equities. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page